Esher-based Spex Capital launches new venture fund
Esher-based digital health and medtech investment management firm Spex Capital has launched a new closed-end fund.
The Spex Venture HealthTech Fund, which has a target size of €100 million, will invest up to €5 million in seed and Series A funding rounds for early-stage healthtech ventures around the world.
Spex Capital, founded by healthtech entrepreneur Claudio D’Angelo, has previously made 10 investments in the medtech sector and has connections to the NHS through an exclusive two-year partnership with London life sciences cluster organisation MedCity. Together, the two organisations have worked on an investment programme which contributes to the flow of around 1,000 healthcare companies developing breakthrough technologies every year.
Claudio D’Angelo, founder and CEO of Spex Capital, said: “Even before COVID-19, the drive for countries to make better use of digital technology in healthcare had already begun. With this fund, our partnership with MedCity, and a broad network of high calibre senior advisors, we will have unparalleled access to invest in the best start-ups within this space.”
Read more - Healthtech firm Arcturis takes space at Oxford Technology Park
